Apheresis Equipment Market Size to Exceed USD 10.01 Bn by 2032

The Apheresis Equipment Market, estimated at USD 4.76 Bn in 2025, is expected to exhibit a CAGR of 11.2% and reach USD 10.01 Bn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

The increasing number of trauma and accident cases globally has posed a significant challenge to the growth of the global apheresis equipment market. Apheresis procedures that involve a collection of specific blood components from donors are a vital part of trauma and critical care management. For instance, according to data from the World Health Organization, road traffic accidents alone resulted in an estimated 1.35 million deaths globally in 2025. The WHO also estimated that 20-50 million people sustain non-fatal injuries from road traffic crashes requiring extensive medical care every year.

Global Apheresis Equipment Market – Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of drugs from one place to another.

COVID-19 had a negative impact on the global apheresis equipment market, attributed to an increase in the spreading of COVID-19 infection. For instance, according to an article published in Wiley by Columbia University Irving Medical Center, New York, U.S., states that the spreading of SARS‐CoV‐2 by contact with a contaminated surface is increasing during apheresis, if more than one operator is using the apheresis instrument during a procedure.

Global Apheresis Equipment Market: Key Developments

The increasing adoption of inorganic growth strategies such as partnerships by market players is expected to aid in the growth of the global apheresis equipment market. For instance, in April 2020, Be The Match BioTherapies a gene therapy company collaborated with Cryoport a management consulting enabling the future of medicine for a new era of life sciences. This partnership will provide access to standardized and optimized apheresis collection, cryopreservation, and bioprocessing processes throughout the U.S. and Europe.

Browse 52 Market Data Tables and 45 Figures spread through 180 Pages and in-depth TOC on “Global Apheresis Equipment Market”- Forecast to 2030, Global Apheresis Equipment Market, By Equipment Type (Disposable Apheresis Kits and Apheresis Machines), By Technology Type (Centrifugation and Membrane Filtration), By Procedure Type (Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others (Lymphopheresis and lipidpheresis)), By Application (Renal disorders, Neurological disorders, Hematological disorders, and Other disorders), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Blood Donation Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/apheresis-market-517

Key Takeaways of the Global Apheresis Equipment Market:

• The global apheresis equipment market is expected to exhibit a CAGR of 11.2% during the forecast period due to the rising number of organ transplant procedures across the globe. For instance, according to data published by the American Transplant Foundation in 2022, over 41,000 organ transplant procedures were completed in the U.S. in the year 2020 alone. The rising number of organ transplant procedures across the globe is a key factor driving the growth of the global apheresis equipment market.
• Among equipment type, the Disposable Apheresis Kits segment is estimated to hold a dominant position in the global apheresis equipment market over the forecast period. For instance, in April 2020, Terumo BCT, Inc. a blood management company received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the use of Terumo BCT's Spectra Optia Apheresis System combined with Marker Therapeutics' D2000 Adsorption Cartridge to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19).
• Among region, North America is expected to be the dominant region in the global apheresis equipment market, owing to the increasing adoption of disposable apheresis kits, which is expected to drive segment growth over the forecast period. For instance, according to the American Red Cross, over 75% of blood collections now utilize apheresis kits that can be used once and safely disposed of. The preference for disposable kits stems from the fact that they eliminate risks of contamination between uses and free up valuable clinician time spent on cleaning and packaging reusable components.
• Major players operating in the global apheresis equipment market include Asahi Kasei Medical Co., Ltd., Terumo Corporation, Inc., Fenwal, Inc., Haemonetics Corp., Therakos, Inc., B. Braun Melsungen AG, HemaCare Corporation, Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Miltenyi Biotec, NxStage Medical, and Kaneka Medix Corporation